United States
Germany
Japan
United Kingdom
China
BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
Products
Anti-BRAF mouse monoclonal antibody, clone OTI4A5 (formerly 4A5)
| Applications | ELISA, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI1E2 (formerly 1E2)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI1D2 (formerly 1D2)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI3C3 (formerly 3C3)
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI4C11 (formerly 4C11)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human, Dog, Mouse, Rat |
BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI1D4 (formerly 1D4)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
CNY 1,999.00
CNY 4,070.00
2周
BRAF mutant V600E Rabbit monoclonal antibody,clone OTIR1F3
| Applications | IHC, WB |
| Reactivities | Human |
Anti-BRAF mouse monoclonal antibody, clone OTI4B2 (formerly 4B2)
| Applications | ELISA, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Knockout (KO) Validation
Modifications
Clonalities
Mutants
Assay Types
Brands
Families
Pathways
- Acute myeloid leukemia (61)
- Bladder cancer (61)
- Chemokine signaling pathway (61)
- Chronic myeloid leukemia (61)
- Colorectal cancer (61)
- Endometrial cancer (61)
- ErbB signaling pathway (61)
- Focal adhesion (61)
- Glioma (61)
- Insulin signaling pathway (61)
- Long-term depression (61)
- Long-term potentiation (61)
- MAPK signaling pathway (61)
- Melanoma (61)
- Natural killer cell mediated cytotoxicity (61)
- Neurotrophin signaling pathway (61)
- Non-small cell lung cancer (61)
- Pancreatic cancer (61)
- Pathways in cancer (61)
- Progesterone-mediated oocyte maturation (61)
- Prostate cancer (61)
- Regulation of actin cytoskeleton (61)
- Renal cell carcinoma (61)
- Thyroid cancer (61)
- Vascular smooth muscle contraction (61)
- mTOR signaling pathway (61)
